How Much Is a Med Spa Worth?

How med spas are priced

Normalize the earnings, then apply a multiple that reflects risk. For a med spa, normalizing has two steps buyers routinely skip. The first is costing in every clinical hour the owner personally delivers. An owner who injects three days a week is producing treatment revenue that a replacement injector would be paid a percentage or a salary to produce, and if that cost is not in the numbers, the reported SDE is inflated by the entire value of a working injector. The second is the medical director fee. If the seller is the physician, or has a friend signing for a nominal amount, the buyer will pay a real market rate — expense it before you value anything.

The general mechanics — what qualifies as an add-back, how SDE differs from EBITDA, how working capital is handled at close — are covered in how to value a business. Below is what is specific to medical spas.

What moves the multiple

• Membership and package mix — The dominant driver. Monthly memberships and prepaid treatment packages produce revenue that recurs without a new marketing dollar, and that is what separates a med spa multiple from a salon multiple. Ask for revenue split by membership, existing-patient, and new-patient for the trailing three years. If growth is coming entirely from new-patient promotions, the practice is buying its revenue every month.
• Injector depth and tenure — Two or three appropriately licensed injectors with multi-year tenure is worth real multiple. One injector who is also the seller is the most common reason a med spa deal reprices.
• Compliance structure — A documented MSO arrangement, a substantive medical director agreement with evidence of actual oversight, and injector scope that matches state rules. This is a floor, not a bonus: buyers with counsel will not pay a premium multiple over a structure they may have to rebuild.
• Device age and service history — Platform lasers and body-contouring systems can run $50,000–$150,000 or more to replace. Current service contracts and devices with useful life remaining keep the practice at the top of the range; an aging fleet is a capital call that comes out of the price.
• Reputation and organic patient flow — A strong local review profile and an owned website producing consultation bookings is a durable asset. A practice dependent on discount platforms and paid social for new patients has a cost line instead.
• Retail and product margin — Skincare retail attached to treatment visits is high-margin and stable, and a practice with a real retail attach rate carries a modest premium.
• Lease and room count — Treatment rooms are the capacity constraint. A practice at full utilization with no expansion room and a short lease has a growth ceiling the buyer inherits.

What pulls the price down

These are the findings that most often reprice a med spa deal between the letter of intent and the closing table. Each one is a reason to bid below the mid-range, or to shift part of the price into a seller note or an earnout rather than paying it at close.

• The owner is the primary injector and has no post-close commitment, or has one that ends before patients have re-formed a relationship.
• Membership revenue is small, or memberships exist on paper with high churn the seller has not disclosed.
• A medical director agreement that is nominal, unsigned, out of date, or paid at a rate no replacement physician would accept.
• Injectors delivering services outside their licensed scope for the state, or supervision requirements documented only informally.
• A large prepaid-package liability on the books — treatments already sold that the buyer must deliver for no new revenue. This is a purchase-price adjustment, not a footnote.
• Devices at or past end of service life, or equipment leases with balances above the machines' market value.
• New-patient acquisition dependent on deep-discount platforms, which trains a patient base that does not convert to membership.

Worked example: a $320,000 SDE single-location med spa

A single-location med spa reports $1.4M of revenue and $320,000 of SDE. The owner is an RN injector treating three days a week and has not expensed that clinical time; a replacement injector at market compensation costs roughly $110,000 fully loaded, and the medical director agreement is with the seller's former colleague at $600 a month against a realistic market rate closer to $2,500. Normalized earnings are therefore nearer to $187,000. At a mid-range 4x, that is about $750,000. Now adjust: roughly 40% of revenue comes from an active membership program with documented multi-year retention (up), two additional licensed injectors have three-plus years of tenure and have signed on to stay (up), but the practice's primary laser platform is eight years old with an estimated $95,000 replacement cost inside two years (down) and there is $60,000 of unredeemed prepaid packages on the books (down, dollar for dollar). A realistic bid lands near $700,000–$780,000, with the prepaid-package balance settled as a purchase-price reduction and the injector employment agreements made a closing condition.

Run the same arithmetic on any listing you are considering. Restate the earnings with every clinical and management role paid at market, subtract the prepaid liability, divide the asking price by what remains, and then ask what in this specific practice justifies its position relative to the 3x–5x range. If the honest answer is that aesthetics is a hot category, you are being asked to pay for someone else's thesis.

Before you rely on any of this

Market ranges orient a first conversation; they do not price a deal. Once you are past the initial screen, get three years of tax returns and reconcile them to the practice-management software rather than to the broker's summary — you want patient counts, membership roster and churn, revenue by service line, and the unredeemed package balance pulled from the system itself. For med spas specifically, also have a healthcare attorney in your state read the ownership structure and the medical director agreement before you sign a letter of intent, because a non-compliant structure is not a diligence finding you negotiate around. Working through our due diligence checklist first is the cheapest money you will spend on the transaction.

Related Guides